Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

The big pharma company AstraZeneca has forged a licensing pact worth $2 billion with the Chinese firm CSPC Pharmaceutical ...

Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...

Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...

Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a ...

The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun hands-on activities from taking apart household mechanics to building ...

Patient recruitment is a critical and often challenging aspect of clinical trials, particularly for biopharmaceutical companies seeking to accelerate drug development. The success of these trials ...

In today’s complex regulatory environment, ensuring weighing data integrity is not just a best practice but a necessity for compliance. However, the benefits of maintaining robust data integrity go ...

Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of pharmaceutical outsourcing. We also delve into the latest trends, the rise of ...